Study of Brolucizumab in Adult Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular Degeneration
Clinical trial NCT04264819 · COMPLETED
Trial details
- NCT number
- NCT04264819
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-14
- Primary completion
- 2022-10-05
- Enrollment
- 295
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.